Herpesvirus 8 (HHV-8) DNA, Quantitative Real-Time PCR
Use
Herpesvirus 8 (HHV-8) DNA, Quantitative Real-Time PCR is used to monitor the level of viremia in a patient, often in the context of therapy. HHV-8 is associated with the development of all forms of Kaposi's sarcoma, as well as some other rare lymphoproliferative diseases, such as primary effusion lymphoma and multicentric Castleman's disease.
Special Instructions
Ensure proper collection and handling of specimens. Specimen type may vary; ensure to submit only one of the specified types (Whole Blood, Serum, or Plasma).
Limitations
The test has not been cleared or approved by the FDA. It is developed and validated by Quest Diagnostics according to CLIA regulations and is used for clinical purposes. Inadequate specimen volume or improper collection may lead to test rejection.
New York Approved
Methodology
PCR-based (RT-PCR)
Biomarkers
LOINC Codes
- 49406-2
- 31208-2
- 49406-2
- 100684-0
Result Turnaround Time
3-6 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
1 mL
Minimum Volume
0.5 mL
Container
Lavender-top (EDTA)
Collection Instructions
Send 1 mL EDTA whole blood refrigerated. Frozen whole blood is not acceptable.
Storage Instructions
Refrigerate
Causes for Rejection
Sodium heparin specimen, Lithium heparin specimen, ACD specimen, Frozen whole blood specimen
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 7 days |
| Frozen | 30 days |